Cargando…
A Novel Doxorubicin Prodrug with Controllable Photolysis Activation for Cancer Chemotherapy
PURPOSE: Doxorubicin (DOX) is a very effective anticancer agent. However, in its pure form, its application is limited by significant cardiotoxic side effects. The purpose of this study was to develop a controllably activatable chemotherapy prodrug of DOX created by blocking its free amine group wit...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2916115/ https://www.ncbi.nlm.nih.gov/pubmed/20596761 http://dx.doi.org/10.1007/s11095-010-0183-x |